Get started
CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

No trades
See on Supercharts
Overview
Analysis
Holdings Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪1.25 B‬ TWD
Fund flows (1Y)
‪−451.57 M‬ TWD
Dividend yield (indicated)
—
Discount/Premium to NAV
−1.5%
Shares outstanding
‪214.48 M‬
Expense ratio
1.05%

About CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV


Issuer
CATHAY FINANCIAL HLDG CO
Brand
Cathay
Home page
cathaysite.com.tw
Inception date
Nov 22, 2021
Structure
Open-Ended Fund
Index tracked
Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Cathay Securities Investment Trust Co., Ltd.
ISIN
TW0000089804
1 90%() 2 1 () 100%

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Health care equipment & services
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of May 14, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.21%
Health Technology96.96%
Health Services2.25%
Bonds, Cash & Other0.79%
Cash0.79%
Stock breakdown by region
64%26%8%
North America64.98%
Europe26.82%
Asia8.19%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows